Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q6953205> ?p ?o }
Showing triples 1 to 25 of
25
with 100 triples per page.
- Q6953205 subject Q7215865.
- Q6953205 subject Q8725943.
- Q6953205 subject Q8788974.
- Q6953205 abstract "NCS-382 is a moderately selective antagonist for the GHB receptor. It blocks the effects of GHB in animals and has both anti-sedative and anticonvulsant effects. It has been proposed as a treatment for GHB overdose in humans as well as the genetic metabolic disorder succinic semialdehyde dehydrogenase deficiency (SSADHD), but has never been developed for clinical use.".
- Q6953205 iupacName "(2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene ethanoic acid".
- Q6953205 thumbnail NCS-382.png?width=300.
- Q6953205 wikiPageWikiLink Q207920.
- Q6953205 wikiPageWikiLink Q2823333.
- Q6953205 wikiPageWikiLink Q3505252.
- Q6953205 wikiPageWikiLink Q410943.
- Q6953205 wikiPageWikiLink Q5513407.
- Q6953205 wikiPageWikiLink Q576618.
- Q6953205 wikiPageWikiLink Q7215865.
- Q6953205 wikiPageWikiLink Q847705.
- Q6953205 wikiPageWikiLink Q8725943.
- Q6953205 wikiPageWikiLink Q8788974.
- Q6953205 iupacname "-".
- Q6953205 type ChemicalCompound.
- Q6953205 type ChemicalSubstance.
- Q6953205 type ChemicalObject.
- Q6953205 type Thing.
- Q6953205 type Q11173.
- Q6953205 comment "NCS-382 is a moderately selective antagonist for the GHB receptor. It blocks the effects of GHB in animals and has both anti-sedative and anticonvulsant effects. It has been proposed as a treatment for GHB overdose in humans as well as the genetic metabolic disorder succinic semialdehyde dehydrogenase deficiency (SSADHD), but has never been developed for clinical use.".
- Q6953205 label "NCS-382".
- Q6953205 depiction NCS-382.png.